Ledger.Open graph →
SEC Form D · filed May 19, 2020

Citius Pharmaceuticals, Inc

Offering
$3.5M
Sold
$221K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CRANFORD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Leonard Mazur · Cranford, NJExec · DirectorCarol Webb · Cranford, NJDirectorEugene Holuka · Cranford, NJDirectorSuren Dutia · Cranford, NJDirectorJaime Bartushak · Cranford, NJExecHoward Safir · Cranford, NJDirectorWilliam Kane · Cranford, NJDirectorMyron Holubiak · Cranford, NJExec · DirectorDavid W. Grieger · SEATTLE, WADirectorSteven E. Pope · SEATTLE, WADirectorCharles E. Mcnerney · SEATTLE, WAExec · DirectorBennett M. Butters · SEATTLE, WADirectorTammy Jennissen · Stamford, CTExecUna E. Ryan · SEATTLE, WADirectorDick E. Henriques · SEATTLE, WADirectorClark W. Donnell · SEATTLE, WAExec · DirectorQili Li · Annandale, VADirectorJesse C. Russell · Bend, ORDirectorRuben M. De La Fuente Jimenez · Boadilla Del Monte, Madrid, U3Exec · DirectorSean Moghavem · Beverly Hills, CAExec · DirectorJames Lockhart · Lithia, FLDirectorJ.P. R. Bourtin · Fredericksburg, TXDirectorJeremy Arendt · Denver, COExecMichael Liang · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗